Skip to main content
. 2012 Jun 16;32(5):507–517. doi: 10.1007/s10792-012-9589-2

Fig. 1.

Fig. 1

Loteprednol etabonate (I) and its inactive metabolites, Δ1 cortienic acid etabonate (II) and Δ1 cortienic acid (III)